Business Wire

  1. American Cancer Society Recommends Guardant Health's Shield Blood Test In Updated Colorectal Cancer Screening Guidelines 5/27/2026

    Guardant Health, Inc. a leading precision oncology company, announced that its FDA-approved Shield blood test is now included in updated American Cancer Society (ACS) Colorectal Cancer (CRC) Screening Guidelines published today.

  2. Argonne Launches First Large-Scale AI Inference Service For Open Science 5/27/2026

    The U.S. Department of Energy’s (DOE) Argonne National Laboratory has launched a first-of-its-kind AI inference service to help researchers across the nation accelerate discovery and innovation.

  3. Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities With New Laboratory In Gothenburg, Sweden 5/18/2026

    Thermo Fisher Scientific, the world leader in serving science, today announced the opening of a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, located within GoCo Health Innovation City.

  4. Valar Labs Receives FDA Breakthrough Device Designation For Vesta Bladder Risk Stratify Dx 5/15/2026

    Valar Labs, an AI precision oncology company developing diagnostics that predict cancer treatment response from routine pathology slides, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Vesta Bladder Risk Stratify Dx. With this designation, Vesta Bladder Risk Stratify Dx becomes the first AI-powered digital pathology prognostic test in bladder cancer to receive FDA Breakthrough status, marking a significant milestone for the field of computational pathology and for patients with bladder cancer.

  5. Charles River Laboratories And MEDIPOST Sign Non-Exclusive MOU To Advance GMP Testing Solutions 5/13/2026

    Charles River Laboratories (CRL) and MEDIPOST Co., Ltd. (KOSDAQ 078160) have entered into a strategic, non-exclusive Memorandum of Understanding (MOU) to collaborate on GMP-compliant testing, as well as broader commercial and marketing efforts to advance cell therapy development and commercialization.

  6. Lucent Diagnostics Announces Collaboration With Tempus To Integrate Blood-Based Alzheimer's Biomarker Testing Into Clinical Workflows 5/6/2026

    Lucent Diagnostics, a brand of Quanterix Corporation, today announced a collaboration with Tempus AI Inc, a technology company leading the adoption of AI to advance precision medicine, to broaden access to a novel blood-based biomarker panel designed to improve detection accuracy for Alzheimer’s disease.

  7. UberDoc Health Technologies Announces Strategic Partnership With XY.AI Labs To Expand Physician Network And Advance AI-Driven Practice Support 4/30/2026

    UberDoc Health Technologies Corp. the direct-pay healthcare marketplace for specialty care, today announced a formal partnership with XY.AI Labs, an agentic AI platform purpose-built for healthcare operations.

  8. Innovative Lab Services Acquires Analytical Instrument Management 4/22/2026

    Innovative Lab Services LLC (“ILS”), a leading provider of analytical instrument services, today announced the acquisition of Analytical Instrument Management (“AIM”), a leading provider of refurbished analytical instrumentation.

  9. Forge Biologics Among Select Global CDMOs To Earn My Green Lab Certification Across All Laboratories And cGMP Suites 4/22/2026

    Forge Biologics, (“Forge”), a leading manufacturer of gene therapies and member of the Ajinomoto Bio-Pharma Services group, today announced it has achieved My Green Lab Certification, the global gold standard for laboratory sustainability best practices, across all of its laboratories and manufacturing suites.

  10. Bruker Launches MyGenius PRO High-Throughput Sample-To-Answer Molecular Diagnostics System At ESCMID 2026 4/17/2026

    At ESCMID Global 2026, the Bruker Microbiology & Infection Diagnostics division (Bruker Corporation, Nasdaq: BRKR) announces the European launch of MyGenius PRO, a fully automated, sample-to-answer (S2A) molecular diagnostics system based on PCR (Polymerase Chain Reaction) technology.